Furthermore, some scFvs show reduced affinity of up to one order of magnitude as compared to the corresponding Fab fragments 9. HBsAg, even through with a lower binding activity. These results have facilitated the starting of further functional analyses of the constructed dsFv, and may therefore provide an improved technique for the production and application of dsFvs against HBsAg. Keywords: HBsAg, Fab, dsFv, phage antibody, chain shuffling, point mutagenesis Introduction The field of recombinant antibodies is usually a fast developing area and has grabbed the attention of a large number of experts 1. In general, the goal is to produce human monoclonal antibodies for disease diagnosis and therapy, a Rabbit polyclonal to COFILIN.Cofilin is ubiquitously expressed in eukaryotic cells where it binds to Actin, thereby regulatingthe rapid cycling of Actin assembly and disassembly, essential for cellular viability. Cofilin 1, alsoknown as Cofilin, non-muscle isoform, is a low molecular weight protein that binds to filamentousF-Actin by bridging two longitudinally-associated Actin subunits, changing the F-Actin filamenttwist. This process is allowed by the dephosphorylation of Cofilin Ser 3 by factors like opsonizedzymosan. Cofilin 2, also known as Cofilin, muscle isoform, exists as two alternatively splicedisoforms. One isoform is known as CFL2a and is expressed in heart and skeletal muscle. The otherisoform is known as CFL2b and is expressed ubiquitously goal that was Imatinib (Gleevec) often unattainable before. The technology of immunoglobulin combinatorial libraries for the generation of monoclonal antibodies has undergone considerable changes since it was first reported in 1989. As the phage display technology progresses, the phage antibody library has been widely used to isolate specific antibody fragments from large antibody gene pools. Compared with standard hybridoma technologies, the human phage antibody technology has more advantages: 1. The process is usually efficient and a relatively large number of antibodies can be produced; Imatinib (Gleevec) 2. It has been suggested that it can mimic the key features of the humoral immune systemin vitroby expressing the antibody fragment gene repertoires around the surfaces of the bacteriophage (phage display). As a result, human antibodies with high affinities can be produced without prior immunization or other conventional monoclonal antibody generation technology; 3. Human antibodies are useful in therapy in human. However, it is extremely hard to make human monoclonal antibodies using standard hybridoma technologies. The use of bacteriophage display libraries of Fab or scFv antibodies on their surfaces has been proven to be efficient for the isolation of a diverse set of human monoclonal antibodies from immune or nonimmune volunteers against a variety of infectious diseases 2,3. In comparison to a full-length antibody, Fab fragment can be very easily expressed in bacterial expression systems 4. Although native unstabilized Fv heterodimers have been made from antibodies 5, Fvs by themselves are generally unstable because the VH and VL domains of the heterodimer can rapidly dissociate 6. This results in drastically reduced binding affinity. Another disadvantage of Fab fragments is the tendency of light chains to form homodimers, which are known as Bence Jones proteins 7. In the mean time, single-chain Fv fragments (scFvs) have a tendency to form aggregates and are relatively unstable over time 8. Furthermore, some scFvs show reduced affinity of up to one order of magnitude as compared to the corresponding Fab fragments 9. One approach to generate stable recombinant Fvs is usually to connect the VH and VL domains by an interdomain disulfide bond instead of a linker peptide. Disulfide-stabilized Fvs (dsFvs) have resolved most of the problems that are associated with scFvs. DsFvs are stable, often show full antigen binding activity, and sometimes even demonstrate better affinity than scFvs 10. During the last two decades, liver transplantation for liver diseases related to hepatitis B computer virus (HBV) infection has been successful 11,12. Administration of high doses of HBIG and lamivudine for prophylaxis during liver transplantation has reduced the risk of the recurrence of HBV and therefore improved the survival of the patients undergoing transplants 13. However, the cost of long-term prophylaxis with high doses of HBIG is extremely high, and lamivudine may lead to the selection of complex mutants 14. The use of HBsAg is considered to be the necessary immunoprophylaxis in complex situations such as immunosuppressive Imatinib (Gleevec) therapy 15,16. In this study, a human immunoglobulin combinatorial library was generated by using a phage surface display expression system. Phage antibodies (Fab fragments) were screened Imatinib (Gleevec) against HBsAg. To improve the affinity of the antibody by chain shuffling, a human antibody light-chain gene repertoire was generated by reverse transcriptase-polymerase chain reaction (RT-PCR) from human peripheral blood lymphocytes. Then, a phage antibody sub-library was constructed by inserting the light-chain gene repertoire into the phagmid that contained the Fd gene. After high-affinity Fab fragment against HBsAg was produced, we constructed dsFvs against HBsAg by using the PCR-based point mutagenesis method. Fab against HBsAg and its dsFv form were expressed in XL1-Blue and helper phage VCSM13 (1012 cfu/ml) were purchased from.